Jonathan Violin
President and Chief Executive Officer
Board Member
Board Member
CEO
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Viridian Therapeutics, Inc.\DE (VRDN) | Former President, Chief Executive Officer and Director | $59,209 | $2,211,072 |
| 2022 | Viridian Therapeutics, Inc.\DE (VRDN) | Former President, Chief Executive Officer and Director | $601,200 | $4,646,740 |
| 2021 | Viridian Therapeutics, Inc.\DE (VRDN) | Former President, Chief Executive Officer and Director | $567,000 | $17,408,538 |
Executive changes
Earnings-call appearances
-
Viridian Therapeutics, Inc.DE Q2 FY2022 Earnings Call2022-08-15
Viridian Therapeutics, Inc.\DE (VRDN)
-
Viridian Therapeutics, Inc.DE Q1 FY2022 Earnings Call2022-05-12
Viridian Therapeutics, Inc.\DE (VRDN)
-
Viridian Therapeutics, Inc.DE Q4 FY2021 Earnings Call2022-03-10
Viridian Therapeutics, Inc.\DE (VRDN)
-
Viridian Therapeutics, Inc.DE Q4 FY2020 Earnings Call2021-03-25
Viridian Therapeutics, Inc.\DE (VRDN)